SNORD11B

Across TCGA pan-cancer cohorts, SNORD11B RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated SNORD11B data layer.

The strongest signal is observed in lymphoid neoplasm diffuse large b-cell lymphoma (DLBC), where higher SNORD11B RNA is associated with worse overall survival. In most high-consensus cancer types, elevated SNORD11B expression acts as an unfavorable survival marker, although some lineages such as SKCM and ESCA show a favorable association.

DLBC, MESO, and LIHC are the cancer types where SNORD11B RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
DLBC	OS	Tertile	All	0.539	1.000	.002	64	view →
MESO	OS	Quartile	II,III,IV	0.376	0.618	.003	60	view →
LIHC	OS	Tertile	All	0.538	0.810	.001	57	view →
UCEC	DFS	Tertile	All	0.742	0.859	.001	48	view →
PRAD	OS	Tertile	All	0.967	0.995	.009	30	view →
THCA	DFS	Tertile	IV	0.601	0.961	.011	18	view →
SKCM	DFS	Tertile	III,IV	0.396	0.174	.012	15	view →
BLCA	DFS	Quartile	II,III,IV	0.549	0.633	.025	15	view →
PCPG	DFS	Tertile	All	0.848	0.939	.022	9	view →
UVM	OS	Tertile	III,IV	0.311	0.906	.022	6	view →
ESCA	DFS	Tertile	All	1.000	0.503	.027	5	view →
SARC	DFS	Tertile	All	0.487	0.276	.038	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

SNORD11B–DLBC (OS)

Open the DLBC breakdown →